...
首页> 外文期刊>Current opinion in cardiology >Recent developments in cardiac output determination by bioimpedance: comparison with invasive cardiac output and potential cardiovascular applications.
【24h】

Recent developments in cardiac output determination by bioimpedance: comparison with invasive cardiac output and potential cardiovascular applications.

机译:通过生物阻抗测定心输出量的最新进展:与有创心输出量和潜在心血管应用的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE OF REVIEW: To describe recent developments in bioimpedance technique and its application in cardiovascular diseases. Cardiac output determination has been used selectively during recent years because of the need for invasive right heart catheterization. Hence, experience with its application in patients with cardiovascular diseases and especially heart failure is limited. Bioimpedance is a novel noninvasive technique determining changes in instantaneous (during one heartbeat) conductance of a small electrical current transferred through the body. By using different algorithms correcting for various body composition constants, it calculates the change in instantaneous arterial blood volume (that is, stroke volume) and cardiac output. Traditionally, bioimpedance cardiac output is determined using either thoracic or whole body techniques according to the location of the electrodes transmitting and receiving the small electrical current. RECENT FINDINGS: Significant progress was achieved in recent years in cardiac output determination by bioimpedance. Newer algorithms using thoracic and whole body bioimpedance have demonstrated better correlation with invasive cardiac output determination. In a few preliminary studies bioimpedance-determined cardiac output was found useful in the diagnosis, risk stratification, and treatment titration of some cardiovascular conditions. Further, larger prospective studies are required to determine the true independent value of cardiac output measurement by bioimpedance for the evaluation of cardiovascular diseases and especially heart failure. SUMMARY: Recently, significant improvement was achieved in cardiac output measurement by bioimpedance with both newer thoracic and whole body techniques. Preliminary studies imply that this measure may be of value in managing some cardiovascular disorders.
机译:审查目的:描述生物阻抗技术的最新发展及其在心血管疾病中的应用。由于需要有创右心导管检查,近年来有选择地使用了心输出量测定。因此,其在心血管疾病尤其是心力衰竭患者中的​​应用经验有限。生物阻抗是一种新颖的非侵入性技术,可确定通过人体传递的小电流的瞬时(一次心跳)电导率的变化。通过使用校正各种身体成分常数的不同算法,它可以计算瞬时动脉血量(即中风量)和心输出量的变化。传统上,根据发射和接收小电流的电极位置,使用胸部或全身技术确定生物阻抗心输出量。最近的发现:近年来,在通过生物阻抗测定心输出量方面取得了重大进展。使用胸腔和全身生物阻抗的较新算法已证明与有创心输出量测定具有更好的相关性。在一些初步研究中,发现生物阻抗确定的心输出量可用于某些心血管疾病的诊断,风险分层和滴定治疗。此外,需要更大的前瞻性研究来确定通过生物阻抗测定心输出量的真正独立值,以评估心血管疾病,尤其是心力衰竭。简介:最近,通过使用新的胸腔和全身技术的生物阻抗,心输出量测量取得了显着改善。初步研究表明,该措施可能对某些心血管疾病的治疗有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号